NEW YORK (360Dx) – By combining three biomarkers, each a harbinger of disease risk, a research group has developed an index that clinicians might be able to use to diagnose the chronic autoimmune condition lupus, or systemic lupus erythematosus (SLE).

The index uses an algorithm to identify the risk of a patient developing lupus based on the concentration in blood serum of IgG and IgM anti-double stranded DNA antibodies, and levels of C1q, a protein complex associated with protection from lupus.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.